Matters

  • Represented Fortune 500 pharmaceutical company in an internal investigation involving allegations of corporate malfeasance.
  • Represented one of the world’s largest retailers in criminal investigation under the Food, Drug and Cosmetic Act.
  • Represented prominent individual before the House Committee on Oversight and Government Reform in its investigation of the administrator of the U.S. General Services Administration.
  • Represented prominent state office in its internal investigation of a former public official’s misconduct.
  • Represented a prestigious national health care system in the internal investigation of allegations of fraudulent billing for clinic services.
  • Represented publicly held company in the internal investigation of insider trading.
  • Represented a publicly traded company in the internal investigation of backdating of option grants for executives.